Providing a diverse range of perspectives from bullish to bearish, 21 analysts have published ratings on Boston Scientific (NYSE:BSX) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 12 | 8 | 1 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 3 | 0 | 0 | 0 | 0 |
| 2M Ago | 6 | 6 | 1 | 0 | 0 |
| 3M Ago | 2 | 2 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $82.81, along with a high estimate of $95.00 and a low estimate of $72.00. This upward trend is evident, with the current average reflecting a 10.93% increase from the previous average price target of $74.65.
Decoding Analyst Ratings: A Detailed Look
The standing of Boston...
Login or create a forever free account to read this news
Sign up/Log in